The Postoperative Recovery Course of Skeletal Muscle Mass in Older Esophageal Cancer Patients

Author:

Harada Tsuyoshi12ORCID,Tsuji Tetsuya13ORCID,Tatematsu Noriatsu4,Ueno Junya1,Koishihara Yu1,Konishi Nobuko1,Yanagisawa Takumi1,Hijikata Nanako1,Ishikawa Aiko13,Fujita Takeo5

Affiliation:

1. Department of Rehabilitation Medicine, National Cancer Center Hospital East, Kashiwa, Chiba, Japan

2. Department of Rehabilitation Medicine, Keio University Graduate School, Shinjuku, Tokyo, Japan

3. Department of Rehabilitation Medicine, Keio University School of Medicine, Shinjuku, Tokyo, Japan

4. Department of Integrated Health Sciences, Nagoya University, Nagoya, Aichi, Japan

5. Department of Esophageal Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan

Abstract

Purpose. Skeletal muscle mass (SMM) is an important biomarker for health in older cancer patients. However, there is limited information on the recovery course of SMM after esophagectomy in older patients. This study aimed to investigate the recovery course of SMM after esophagectomy and the predictors in older cancer patients. Methods. We conducted a single-center, retrospective cohort study. Esophageal cancer patients who underwent esophagectomy were included. The skeletal muscle mass index (SMI) was calculated using computed tomography images. The loss of SMI at 4 and 12 months after surgery was calculated as [(preoperative − postoperative SMI) ÷ preoperative SMI] × 100%. Nonrecovery was defined as an SMI loss of ≥2% at 12 months after surgery, considering physiological loss with aging. One-way analysis of variance and multivariate logistic regression analysis was used for statistical analysis. Results. A total of 105 older (≥70 years) and 156 nonolder (<70 years) patients were analyzed. Older patients had a significantly larger loss of SMI 4 months (mean: 5.7% vs. 3.1%; p = 0.021 ) and 12 months (mean: 1.0% vs. −1.4%; p = 0.040 ) after surgery than nonolder patients. In older patients, the number of patients with nonrecovery of SMI at 12 months after surgery was 55 (52%). In older patients, significant predictors for the nonrecovery of SMI were preoperative sarcopenia (adjusted OR: 0.297; p = 0.012 ), neoadjuvant chemotherapy (adjusted OR: 0.248; p = 0.015 ), and loss of SMI 4 months after surgery (per 1%; adjusted OR: 1.076; p = 0.018 ). Conclusions. It is suggested that older esophageal cancer patients have a larger unmet need for long-term postoperative loss of SMM than nonolder patients. Continuous outpatient rehabilitation, including exercise and nutritional therapy after discharge, which targets improvement in SMM at 4 months, may improve SMI at 12 months after surgery in older esophageal cancer patients.

Publisher

Hindawi Limited

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3